XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions - Fair Value of Purchase Consideration and Measurement Period Adjustments (Details) - BioDelivery Sciences International, Inc - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 22, 2022
Mar. 31, 2023
Business Acquisition [Line Items]    
Cash consideration for all outstanding shares of BDSI's common and preferred stock (103,235,298 shares acquired at $5.60 per share) $ 578,118  
Cash consideration paid to settle RSUs and in-the-money options 28,309  
Cash paid to settle BDSI debt 63,004  
Total purchase consideration $ 669,431  
Shares of stock acquired 103,235,298  
Share price (in dollars per share) $ 5.60  
Accrued expenses   $ 134
Deferred tax liabilities   28
Goodwill   $ 162